Background
==========

In order to develop an understanding of the roles of proteins in cellular dynamics, especially for the purposes of uncovering key players in disease development and for discovery of novel therapeutic targets, their physiological interactions must first be understood \[[@B1]\]. The specialized functions of the differentiated cell types which are assembled into tissues or organs depend on the combinatorial arrangements of proteins and their physical interactions. \[[@B2]-[@B4]\]. A major current challenge is therefore to understand the functions of various types of biological networks, including PINs. \[[@B5]-[@B16]\].

A predominant question in the analysis of PINs continues to be whether biological characteristics and functions of proteins such as lethality, physiological malfunctions and malignancy are intimately linked to the topological role proteins play in the network \[[@B17]-[@B21]\]. Much of the recent efforts in the analysis of protein-protein interaction (PPI) networks has therefore focused on finding functional dependencies between so-called hubs, defined as proteins involved in many interactions, and their topological roles in the network \[[@B22]-[@B24]\].

In the literature, nodes of PINs have been ranked by metrics such as degree, betweenness, eccentricity and closeness. The latter, which is defined as the reciprocal of the average geodetic distance between a given node and others, has particularly featured \[[@B25]\]. Using these metrics, a classification of proteins into core and periphery classes has been defined as a way to predict a protein's relative importance in the network.

It has been reported that disease lethal genes are located in the 'core' of PPI networks \[[@B26]-[@B28]\]. Moreover, it has also been shown that highly connected proteins that are also functionally important are also *topologically* centered and are locally and globally important nodes in the core network \[[@B29]\] and that those with housekeeping functions are mainly located in close proximity to the topological core of the interactome \[[@B2]\]. Similarly, Vinogradov \[[@B30]\] showed that PINs of *Saccharomyces cerevisiae* and *Escherichia coli* consist of two large-scale modularity layers: central and peripheral, separated by a zone of depressed modularity. The categories of the central layer are mostly related to nuclear information processing, regulation and cell cycle, whereas the peripheral layer is dealing with various metabolic and energetic processes, transport and cell communication. Ignacio et al. \[[@B25]\] has developed 'k-core decomposition', a tool which enables the disentangling of the hierarchical structure of networks by progressively focusing on their central cores. The k-core analyses of PINs showed that drug-targets tend to be closer to the topological core \[[@B31]\].

We have recently showed, by using a more precise approach that formally models PINs as metric spaces and classifies proteins into zones based on their distance from the topological centre, that hub proteins are not distributed randomly and are in fact the main feature of zones closest to the network centre. \[[@B32]\]. Furthermore, we intimated that these zones have likely functional significance and proposed that centrally located proteins of both human functional protein interaction network (HFPIN) and the a curated human signalling network (HSN) may present good therapeutic targets. Here, we present further evidence to support our hypothesis and show that the functional and graph-theoretic properties of zones of both human PINs have biological significance. We provide a strategy of identifying possible potential for supporting therapeutic target discovery.

Results and discussion
======================

Human PINs have a core-periphery structure when modelled as metric spaces
-------------------------------------------------------------------------

We modelled the HFPIN \[[@B33]\], which consists of 9448 nodes and 181706 interactions and the highly curated and currently largest available HSN \[[@B34],[@B35]\], which consists of 6291 nodes and 62737 interactions (<http://www.bri.nrc.ca/wang/>). To do so, we first identified each network's topological centre(s) using a formal method that finds the protein(s) that has the smallest maximal distance to other proteins in the network. This locates the protein at the *true* centre of the network, and does not assume that it has the highest number of connections/interactions. Once each network centre was identified, all proteins were categorized into zones based on their distance from the centre, which was defined as the *smallest* number of interactions that have to be traversed from any protein to reach the centre. For example, proteins were categorized as being in zone 1 if they directly interact with the centre and are this one distance unit away from it. Similarly, zone 2 proteins interact with *at least* one zone 1 protein and possibly also other proteins in other zones, but not directly with the centre and are thus 2 distance units away from it, etc.

The main aim of finding the centre of the network was to classify proteins into zones so as to further analyse them from a systems point of view. When we partitioned proteins into zones based on their distance from the centre, the metric structures of the networks could be summarized as follows:

1\. Both have a single protein as their topological centre: MAPK14 and MAPK1 respectively, for HFPIN and HSN. These proteins are members of the MAP kinase family and have been featured as drug targets \[[@B36],[@B37]\].

2\. HFPIN was found to contain 9 zones and HSN 6. We identified several features that support the core-periphery structure proposed for PPI networks. For purposes of further discussion, the zone closest to the centre will be referred to as zone 1.

In both networks, proteins in zone 1 was found to be the most connected with an average degree 86 and 67 respectively for HFPIN and HSN. Overall, 92% and 95% respectively of nodes are located in zones 1 to zone 3 for HFPIN and HSN. Zones 6 to 9 for HFPIN and zones 5 to 6 for HSN consist only of 'quills' (nodes that have degree 1) \[[@B32]\]. It is clear that the HPFIN and HSN structures therefore both have densely connected kernels that rapidly become more sparsely connected towards their peripheries (Table [1](#T1){ref-type="table"}).

###### 

Graph metrics of human PINs modeled with respect to distance from the centre

  **PIN**    **Nodes**   **Edges**   **Diameter**   **Centre**   **Zones around centre**                                                                    
  --------- ----------- ----------- -------------- ------------ ------------------------- -------- -------- ------- ------- ------- ------- ------- ------- ------------
                                                                          **1**            **2**    **3**    **4**   **5**   **6**   **7**   **8**   **9**        
                                                                           374              4610     3464     578     104     14       2       1       1       Nodes
                                                                         **86**            **32**   **52**     2       2       1       1       2       1     Ave degree
  HFPIN        9448       181706          13        **MAPK14**              3                1        1        1       1       1       1       2       1     Min degree
                                                                           531              430      393      14       6       2       2       2       1     Max degree
                                                                            0               173      653      307     56      12       1       0       1     \# quills
                                                                           431              3527     1929     206     38       4                               Nodes
                                                                         **67**            **24**   **7**      2       2       3                             Ave degree
  HSN          6291        62737          11        **MAPK1**               1                1        1        1       1       1                             Min degree
                                                                           451              362       89      11       9       5                             Max degree
                                                                            4               404      757      133     20       2                             \# quills
                                                                           542              6011     3352     367     61       4       1       1       1       Nodes
                                                                         **95**            **34**   **49**     2       2       1       2       2       1     Ave degree
  CN           10573      210689          13        **MAPK3**               1                1        1        1       1       1       2       2       1     Min degree
                                                                           590              431      394      12       6       2       2       2       1     Max degree
                                                                            1               339      831      212     40       3       0       0       1     \# quills

Zones of both human PINs are functionally specialised
-----------------------------------------------------

A summary of enriched pathway analysis reveals that specialization in protein functions and organizing principles are essentially identical in the two networks. While the total numbers of proteins in the two networks are significantly different, the proportions of proteins contributing to key functions and pathways in each zone are remarkably similar (Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). Further, all between-zone differences in proportions of proteins involved in enriched functions were found to be statistically significant using a z-test (P \< 0.01) in both networks. The distribution of all important cellular functions across the zones have essentially identical patterns.

###### 

Functional specialization of HFPIN zones defined by distance from the network centre

  **Enriched Pathway**                          **Zone 1**   **Zone 2**   **Zone 3**   **Zone 4**   **Zone 5**
  -------------------------------------------- ------------ ------------ ------------ ------------ ------------
  Signal transduction                            38.1*%*      26.4*%*         \-           \-           \-
  Immune system                                  31.3*%*        8*%*        5.1*%*         \-           \-
  Hemostasis                                     18.4*%*       5.9*%*       2.5*%*         \-           \-
  Disease                                        17.5*%*       9.1*%*       4.4*%*         \-           \-
  Gene Expression                                 7.9*%*       8.8*%*      11.9*%*         \-           \-
  Metabolism                                     10.7*%*       9.1*%*       8.7*%*      11.3*%*      16.3*%*
  Transmembrane transport of small molecules        \-          2*%*        2.5*%*       3.9*%*      13.4*%*
  Metabolic pathways                              2.4*%*       4.8*%*       6.7*%*      12.7*%*       25*%*

Percentages indicate proportion of proteins in a zone belonging to the specific functional class.

###### 

Functional specialization of HSN zones defined by distance from the network centre

  **Enriched Pathway**      **Zone 1**   **Zone 2**   **Zone 3**   **Zone 4**
  ------------------------ ------------ ------------ ------------ ------------
  Signal transduction        40.6*%*      21.1*%*       9.3*%*       16*%*
  Immune system              33.6*%*      16.2*%*       8.4*%*         \-
  MAPK signalling            28.9*%*       3.5*%*         \-           \-
  Pathways in cancer         21.4*%*       5.7*%*         \-           \-
  Disease                     21*%*        10*%*        7.2*%*       9.8*%*
  Hemostasis                 16.5*%*       6.9*%*       3.3*%*         \-
  Cell Cycle                  5.3*%*       7.6*%*       3.4*%*         \-
  Gene expression             7.2*%*       7.5*%*       8.7*%*         \-
  Metabolism of proteins        \-         4.6*%*       4.6*%*         \-

Percentages indicate proportion of proteins in a zone belonging to the specific functional class.

We observed statistically significant (Bonferroni corrected P-value \< 0.01) functional enrichment in specific zones of the human PINs. Further, we observed in general that zones proximal to the centre appear to be more involved and specialized for key biological functions, with the proteins in those zones involved in only a few pathways. In contrast, zones distal from the centre appear to be more functionally diverse and are enriched for pathways involved in more routine functions. All differences between zones were confirmed to be statistically significant (P \< 0.01). Zone 1 is highly enriched for proteins involved in signal transduction, the immune system, hemostasis and disease pathways and appears to constitute of a core of highly important interactions required for organism and cellular sensing and response to adverse environmental, biological and mechanical stresses. Zone 2 is also enriched for proteins involved in signal transduction and immune system pathways and is moderately enriched for gene expression and metabolic pathways, which are the main functional themes in zone 3. From zone 4 onwards, proteins have significantly less enrichment than zones closer to the centre, with metabolism, metabolic pathways, metabolism of proteins, membrane trafficking and transmembrane transport of small molecules being the main functional themes.

The human functional protein interaction network has a highly connected signalling core
---------------------------------------------------------------------------------------

Due to the proportional statistical over-representation of signal transduction pathways in the zones closest to the centre, their known importance in cellular functions and their prominence as a drug target category, we explored the distribution of proteins having any signalling function, as well as functions related to regulation of signalling (Table [4](#T4){ref-type="table"}). All differences between proportions of signalling related proteins between zones were found to be statistically significant (P \< 0.01).

###### 

Summary of cellular function in the central zones of HFPIN

  **Cellular**                                   **\# of proteins**   **Zone 1**     **Zone 2**    **Zone 3**
  --------------------------------------------- -------------------- ------------- -------------- -------------
  Signalling pathway                                    3186          285 (76.2%)   2141 (46.4%)   760 (20.8%)
  Positive signals                                      544            75 (20%)      386 (8.3%)     83 (2.2%)
  Negative signals                                      449           57 (15.2%)     321 (6.9%)     71 (1.9%)
  MAPK signalling cascade                               394           93 (24.8%)     258 (5.5%)     43 (1.1%)
  Apoptosis signalling pathway                           38            13 (3.4%)     19 (0.4%)      6 (0.1%)
  Positive regulation of apoptosis signalling            22            6 (1.6%)      13 (0.2%)      3 (0.1%)
  Negative regulation of apoptosis signalling            10             4 (1%)       3 (0.06%)      3 (0.08%)

Percentages indicate proportion of proteins in a zone belonging to the specific functional class.

As we have shown that the zones closest to the centre are highly connected, it appears that a very important feature of the HFPIN is a highly connected signalling core, which may flexibly modulate responses to extracellular and intracellular stimuli via a large number of possible shortest paths to the rest of the network. It is likely that such signals emanate from within and between the innermost zones of HFPIN (zones 1 and 2), which are significantly enriched for signalling functions and where the largest number of possible of interactions occur amongst signalling proteins and with other important proteins. As almost all known diseases exhibitdysfunctional signalling networks \[[@B38]\], the extreme enrichment of zones 1 and 2 for signalling pathway functions makes the proteins in those belonging to that functional class potentially high priority novel drug target candidates.

Essential, disease related, tumour suppressor, oncogenic and therapeutic target proteins are centrally located in human PINs
----------------------------------------------------------------------------------------------------------------------------

We extracted a list of human proteins that are likely to be essential based on the fact that knockouts of their orthologs in mice are annotated in the Mouse Genome Database as producing pre-, peri- and post-natal lethal phenotypes. These proteins comprise 43%, 21.7%, 10.7%, 9.3% and 9.6% of proteins in zones 1, zone 2, zone 3, zone 4 and zone 5 respectively of HFPIN and the differences between zones were confirmed to be statistically significant (P \< 0.01).

We also determined in HFPIN the distribution of proteins annotated as being involved in at least one disease by the Disease Ontology Project \[[@B39]\]. Zones 1 to 6 were found to contain 159, 1184, 545, 85, 19 and 2 disease related proteins respectively. While zone 2 contains the largest number of disease gene products, the same pattern is displayed as for essential gene products, with 42.5%, 25.7%, 14.9%, 14.7%, 18.3% and 14.3% of proteins occurring in zones 1 to 6 respectively, being classified as such. The evidence strongly suggests that zones closest to the topological centre contain the largest numbers and proportions of important proteins, with zone 1 on the whole appearing to be most sensitive to aberrations.

We further tested this new hypothesis by determining the distribution of 49 known oncogenes and 62 suppressor genes \[[@B40]\]. Again, the majority of those proteins are located in zones 1 and 2 with zone 1 again having the highest proportion of its proteins belonging to those functional classes, with 4%, 0.6%, 0.02% and 0.1% of proteins in zones 1 to 4 being products of oncogenes, and 3.7%, 0.9%, 0.1% and 0.3%, respectively being tumour suppressors.

In order to determine whether the clear dominance of zone 1 and 2 proteins in essential roles and the diseases have potential implications for drug discovery, we assessed the zone distribution of 497 clinically approved human drug target proteins extracted from the Therapeutic Target Database \[[@B41]\]. The pattern of distribution is virtually identical to the aforementioned categories, where 497 proteins tested comprise 15.7%, 7.5%, 2.1% and 1.8% of proteins in zones 1 to 4, respectively and the differences between zones were again confirmed to be statistically significant (P \< 0.01). As with the other protein functional classes tested, zone 1 contains proportionally the largest percentage of drug targets and approximately double that of zone 2, despite containing only 10% as many proteins. Further, more peripheral zones have comparatively much lesser numbers, and we therefore propose that proteins in zone 1 and 2 should be given priority in the search for novel drug target candidates and disease genes (Table [5](#T5){ref-type="table"}).

###### 

Distribution of essential, disease, drug target and classical cancer proteins in HFPIN zones

  **Zone**    **Essential**   **Disease**     **Drug**    **Oncogenes**   **Tumour**
  ---------- --------------- -------------- ------------ --------------- ------------
  1             161 (43%)     159 (42.5%)    59 (15.7%)      15 (4%)      14 (3.7%)
  2           1002 (21.7%)    1184 (25.6%)   346 (7.5%)     32 (0.7%)     42 (0.9%)
  3            392 (10.7%)    545 (14.9%)    77 (2.1%)      1 (0.02%)      4 (0.1%)
  4             55 (9.3%)      85 (14.4%)    11 (1.8%)      1 (0.2%)       2 (0.3%)
  5             10 (9.6%)      19 (18.2%)     3 (2.8%)         \-             \-
  6                \-          2 (14.2%)      1 (7.1%)         \-             \-

Surprisingly similar and statistically significant patterns were seen in the HSN (Table [6](#T6){ref-type="table"}) and the distribution of all important cellular functions is essentially identical to the HFPIN.

###### 

Distribution of essential, drug target and classical cancer proteins in HSN zones

  **Zone**    **Essential**    **Drug**    **Oncogenes**   **Tumour**
  ---------- --------------- ------------ --------------- ------------
  1            157 (36.4%)     69 (16%)      12 (2.7%)     12 (2.7%)
  2            815 (23.1%)    291 (8.2%)     33 (0.9%)     41 (1.1%)
  3            268 (13.8%)    103 (5.3%)     4 (0.02%)      4 (0.2%)
  4             29 (14%)       5 (2.4%)         \-             \-
  5             4 (10.5%)      1 (2.6%)         \-          1 (2.6%)

The majority of consistently expressed proteins in cancers are located in zones closest to the centre of human PINs
-------------------------------------------------------------------------------------------------------------------

Using absence/presence calls from the Gene Expression Barcode database, we identified genes which are consistently expressed in more than 99% of samples of a given cancer and mapped them onto the zones in which they occur in the human PINs. We found that these proteins are primarily located in zones closest to the centre of human PINs (Tables [7](#T7){ref-type="table"} and [8](#T8){ref-type="table"}). Most of these are located in zone 2, followed by zone 3 and zone 1. In the periphery, the percentage gradually decreases up to zone 6, after which they are absent.

###### 

HFPIN zone distribution of proteins consistently expressed in cancer samples

  **Type of cancer**    **\# proteins**   **Zone 1**   **Zone 2**    **Zone 3**    **Zone 4**   **Zone 5**   **Zone 6**
  -------------------- ----------------- ------------ ------------- ------------- ------------ ------------ ------------
  Breast                      330         11 (3.3%)    189 (57.2%)   121 (36.6%)    9 (2.7%)        \-           \-
  Cervical                    711         26 (3.6%)    425 (59.7%)   230 (32.3%)   23 (3.2%)     7 (0.9%)        \-
  Endometrial                1515         57 (3.7%)    839 (55.3%)   514 (33.9%)   83 (5.4%)    20 (1.3%)     2 (0.1%)
  Fallopian                  1292         49 (3.7%)    715 (55.3%)   446 (34.5%)   67 (5.1%)     14 (1%)     1 (0.07%)
  Glioblastoma               1046         38 (3.6%)    589 (56.3%)   368 (35.1%)   44 (4.2%)     6 (0.5%)     1 (0.9%)
  Glioma                     1180         40 (3.3%)    621 (57.7%)   440 (37.2%)   63 (5.3%)    13 (1.1%)     3 (0.2%)
  Kidney                      561         14 (2.4%)     331 (59%)    193 (34.4%)    23 (4%)         \-           \-
  Liver                       715          29 (4%)     402 (56.2%)   247 (34.5%)   33 (4.6%)     4 (0.5%)        \-
  Lung                        532         19 (3.5%)     314 (59%)    175 (32.8%)   22 (4.1%)     2 (0.3%)        \-
  Ovarian                     775         26 (3.3%)    432 (55.7%)    279 (36%)    32 (4.1%)     6 (0.7%)        \-
  Pancreatic                  717         30 (4.1%)    411 (57.3%)    244 (34%)    28 (3.9%)     4 (0.5%)        \-
  Pituitary                  1126         37 (3.2%)    591 (52.4%)   421 (37.3%)   61 (5.4%)    15 (1.3%)    1 (0.08%)
  Rectal                     1597         69 (4.3%)    861 (53.9%)   552 (34.5%)   90 (5.6%)    23 (1.4%)     2 (0.1%)
  **Average**                              **3.5%**     **56.5%**     **34.8%**     **4.4%**     **0.7%**     **0.1%**

###### 

HSN distribution of proteins consistently expressed in cancer samples

  **Type of cancer**    **\# proteins**   **Zone 1**   **Zone 2**    **Zone 3**    **Zone 4**   **Zone 5**   **Zone 6**
  -------------------- ----------------- ------------ ------------- ------------- ------------ ------------ ------------
  Breast                      236          12 (5%)     151 (63.9%)   70 (29.6%)     2 (0.8%)     1 (0.4%)        \-
  Cervical                    533         42 (7.8%)    323 (60.6%)   157 (29.4%)    9 (1.6%)     1 (0.1%)     1 (0.1%)
  Endometrial                1092         89 (8.1%)    647 (59.2%)   336 (30.7%)   17 (1.5%)     2 (0.1%)    1 (0.09%)
  Fallopian                   941         72 (7.6%)    563 (59.8%)   287 (30.4%)   16 (1.7%)     2 (0.2%)     1 (0.1%)
  Glioblastoma                767         64 (8.3%)    471 (61.4%)   216 (28.1%)   13 (1.6%)     2 (0.2%)     1 (0.1%)
  Glioma                      824          35 (8%)      278 (64%)    114 (62.2%)    5 (1.1%)     1 (0.2%)     1 (0.2%)
  Kidney                      434         14 (2.4%)     331 (59%)    193 (34.4%)    23 (4%)         \-           \-
  Liver                       537         45 (8.3%)     328 (61%)    155 (28.8%)    7 (1.3%)     1 (0.1%)     1 (0.1%)
  Lung                        422         31 (7.3%)    260 (61.6%)   121 (28.6%)    8 (1.9%)     2 (0.4%)        \-
  Ovarian                     557          39 (7%)     334 (59.9%)   174 (31.2%)    8 (1.4%)     1 (0.1%)     1 (0.1%)
  Pancreatic                  536         46 (8.5%)    332 (61.9%)   148 (27.6%)    8 (1.4%)     1 (0.1%)     1 (0.1%)
  Pituitary                   789          56 (7%)      458 (58%)     253 (32%)    19 (2.4%)     2 (0.2%)     1 (0.1%)
  Rectal                     1162         95 (8.1%)    677 (58.2%)   365 (31.4%)   21 (1.8%)     3 (0.2%)     1 (0.8%)
  **Average**                              **7.5%**     **60.6%**     **29.6%**     **1.5%**     **0.2%**     **0.1%**

Proteins located in zones closest to the HFPIN's centre dominate important and disease pathways
-----------------------------------------------------------------------------------------------

In order to determine whether the enrichment for specific pathways in zones closest to the centre are in concordance with the proportions of proteins from those zones in the said pathways, we mapped HFPIN zone locations to proteins in KEGG pathways \[[@B42]\] using the KEGG Mapper facility (<http://www.genome.jp/kegg/tool/map_pathway2.html>). Strikingly, proteins from zone 1 of the HFPIN comprise a significant proportion of key pathways despite the fact that zones 2 and 3 contain approximately 10 times as many proteins. Furthermore, the vast majority of proteins involved in KEGG 'pathways in cancer', 'MAPK-signalling', 'cell cycle' and 'apoptosis' are from zones 1 and 2 (Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}, respectively). This dominance may be surprising given that the HFPIN represents less than half of known human proteins. Similar patterns are seen in the melanoma pathway and also in pathways for non-neoplastic diseases such as measles, inflammatory bowel disease and Alzheimer's disease (Additional files [1](#S1){ref-type="supplementary-material"}, [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"} and [4](#S4){ref-type="supplementary-material"}, respectively). Also interesting is the observation that distinct sub-pathways are comprised of proteins from a specific zone. For example, in the melanoma pathway, all proteins involved in the cell cycle are located in zone 1. For the cell cycle pathway itself, all components of the origin recognition complex are from zone 1, while all in the mini-chromosome maintenance complex are from zone 2, which we propose adds further credence to our hypothesis that grouping proteins in PINs based on distances from the topological centre has biological significance. It is also apparent that proteins positioned closest to the topological centre of the HFPIN are involved in key roles within important cellular pathways as well as those leading to disease.

![**KEGG 'Pathways in Cancer'.** (Zone 1: red, zone 2: orange, zone 3: yellow).](1752-0509-8-68-1){#F1}

![**KEGG MAPK signalling pathway.** (Zone 1: red, zone 2: orange, zone 3: yellow).](1752-0509-8-68-2){#F2}

![**KEGG Cell-cycle pathway.** (Zone 1: red, zone 2: orange, zone 3: yellow).](1752-0509-8-68-3){#F3}

![**KEGG Apoptosis pathway.** Zone 1: red, zone 2: orange.](1752-0509-8-68-4){#F4}

Central zones of a combined network display increased bias for disease-linked and drug target proteins
------------------------------------------------------------------------------------------------------

We non-redundantly merged the HFPIN and the HSN into a combined network (CN) of 10573 nodes and 210689 interactions and modelled it as a metric space. Even though the core-periphery structure of the CN is similar to those of the original networks, the proportional sizes and connectivity of its zones 1 and 2 are significantly increased (Table [1](#T1){ref-type="table"}). In line with our hypothesis on the cellular importance of central zones, the involvement of those zones in signal transduction and disease pathways is also increased (Table [9](#T9){ref-type="table"}). Similar to HFPIN and HSN, zones closest to the centre of the CN also has the highest proportional representation of signalling functions (Table [10](#T10){ref-type="table"}), essential, drug target and classical cancer proteins (Table [11](#T11){ref-type="table"}) and proteins consistently expressed by specific cancers (Table [12](#T12){ref-type="table"}). However, we propose that the drug discovery potential of our metric space model of the CN is further increased compared to the individual networks due to the higher number of proteins and hubs in its central zones. This was further supported when we mapped proteins onto KEGG pathways as before and found that CN zone 1 proteins feature even more prominently in key pathways than does the equivalent in HFPIN. Coloured pathway maps can be downloaded from <ftp://ftp.sanbi.ac.za/junaid/bmc2/CN_colored_maps.zip>.

###### 

Functional specialization of CN zones defined by distance from the network centre

  **Enriched Pathway**    **Zone 1**   **Zone 2**   **Zone 3**   **Zone 4**
  ---------------------- ------------ ------------ ------------ ------------
  Signal transduction       43*%*       21.6*%*         \-           \-
  Immune system             32*%*       10.9*%*       5.4*%*         \-
  MAPK signalling          25.8*%*       2.3*%*         \-           \-
  Pathway in cancer        20.7*%*       3.5*%*         \-           \-
  Disease                  22.6*%*       9.3*%*       5.4*%*         \-
  Hemostasis               15.9*%*       5.3*%*         \-           \-
  Cell Cycle                5.4*%*       5.5*%*       3.1*%*         \-
  Gene expression           7.8*%*       8.3*%*      12.5*%*         \-
  Metabolism               13.1*%*       9.3*%*       8.8*%*      15.9*%*

Percentages indicate proportion of proteins in a zone belonging to the specific functional class.

###### 

Distribution of signalling related functions in HFPIN and CN zones

                          **HPFIN**       **CN**                                                
  --------------------- ------------- -------------- ------------- ------------- -------------- -----------
  Signalling             285 (76.2%)   2141 (46.4%)   760 (20.8%)   397 (73.2%)   2434 (40.4%)   640 (19%)
  Positive regulation     75 (20%)      386 (8.3%)     83 (2.2%)    123 (22.6%)    393 (6.5%)    50 (1.4%)
  Negative regulation    57 (15.2%)     321 (6.9%)     71 (1.9%)    82 (15.1%)     344 (5.7%)    54 (1.6%)
  MAPK signalling        93 (24.8%)     258 (5.5%)     43 (1.1%)    139 (25.6%)    249 (4.1%)    20 (0.5%)

###### 

Distribution of essential, drug target and classical cancer proteins in CN zones

  **Zone**    **Essential**   **Disease**     **Drug**    **Oncogenes**   **Tumour**
  ---------- --------------- -------------- ------------ --------------- ------------
  1             206 (38%)     234 (43.2%)    97 (17.8%)     17 (3.1%)     20 (3.6%)
  2            1084 (18%)     1279 (21.3%)    365 (6%)      32 (0.5%)     42 (0.6%)
  3            315 (9.3%)     415 (12.4%)    59 (1.7%)      2 (0.05%)      4 (0.1%)
  4             28 (7.6%)      56 (15.3%)     3 (0.8%)      1 (0.2%)       1 (0.2%)
  5             2 (3.2%)       9 (14.8%)      1 (1.6%)         \-             \-

###### 

CN distribution of proteins consistently expressed in cancer samples

  **Type of cancer**    **\# proteins**   **Zone 1**      **Zone 2**      **Zone 3**     **Zone 4**    **Zone 5**
  -------------------- ----------------- ------------- ---------------- --------------- ------------- -------------
  Breast                      350         24 (6.8*%*)    224 (64*%*)     95 (27.1*%*)     7 (2*%*)         \-
  Cervical                    760         43 (5.6*%*)   496 (65.2*%*)    203 (26.7*%*)   16 (2.1*%*)   2 (0.2*%*)
  Endometrial                1644         91 (5.5*%*)   1007 (61.2*%*)   474 (28.8*%*)   61 (3.7*%*)   11 (0.6*%*)
  Fallopian                  1408          71 (5*%*)    869 (61.7*%*)     409 (29*%*)    51 (3.6*%*)   8 (0.5*%*)
  Glioblastoma               1128         63 (5.5*%*)   719 (63.7*%*)    311 (27.5*%*)   30 (2.6*%*)   5 (0.4*%*)
  Glioma                     1270         67 (5.2*%*)   765 (60.2*%*)    380 (29.9*%*)   48 (3.7*%*)   10 (0.7*%*)
  Kidney                      593         44 (7.4*%*)   389 (65.5*%*)    150 (25.2*%*)   10 (1.6*%*)       \-
  Liver                       769         51 (6.6*%*)   475 (61.7*%*)    221 (28.9*%*)   21 (2.7*%*)   1 (0.1*%*)
  Lung                        571         39 (6.8*%*)   369 (64.6*%*)    153 (26.7*%*)   9 (1.5*%*)    1 (0.1*%*)
  Ovarian                     823         37 (4.4*%*)   524 (63.6*%*)    236 (28.6*%*)   23 (2.7*%*)   3 (0.3*%*)
  Pancreatic                  771         44 (5.7*%*)   483 (62.6*%*)    223 (28.9*%*)   21 (2.7*%*)       \-
  Pituitary                  1228         60 (4.8*%*)    738 (60*%*)     373 (30.3*%*)   47 (3.8*%*)   10 (0.8*%*)
  Rectal                     1753         96 (5.4*%*)   1061 (60.5*%*)   515 (29.3*%*)   70 (3.9*%*)   11 (0.6*%*)
  **Average**                              **5.7%**       **62.7%**        **28.2%**      **2.8%**      **0.3%**

Conclusion
==========

Our over-representation analysis on zones depending on the distance from the centre of network has shown that innermost zones of the human PINs are enriched for critically important proteins are functionally specialized. In addition, the majority of known disease-associated and drug target proteins are located in the first two zones. We therefore posit that other proteins in these centralpositions have similar importance, with zone 1 being particularly enriched for signal transduction proteins, an important class of therapeutic targets. We therefore propose that when considered holistically, central proteins having similar functions to existing drug targets are also potential targets for novel therapeutics. Similarly, based on our observation that disease pathways are dominated by central proteins, we propose that genes shortlisted in genome scale disease studies can be further prioritized based on whether their protein products occupy central positions in the human PINs. Further, the increased concentration of known therapeutic targets in zone 1 of the combined network compared to the other networks, along with its increase in the total number of proteins and average number of interactions, indicates that adding the information from the highly curated human signalling network to human PPI networks may significantly improve their utility in disease gene and drug target discovery.

Methods
=======

Zones data sources
------------------

We consider zones of the human PINs as described previously \[[@B32]\]. We also non-redundantly merged the HFPIN and the HSN into a combined network. Proteins from all three networks classified into zones relative to the centre can be downloaded from <ftp://ftp.sanbi.ac.za/junaid/bmc2/Zones_in_PPI_networks.zip>.

Functional enrichment analysis
------------------------------

In order to determine whether zones of the human PINs have biological significance, we divided proteins into subsets based on their distance from the true topological centre. Protein sets representing each zone was then subjected to a pathway over-representation analysis in order to determine whether the zones were specialized for specific functions. The Comparative Toxigenomics Database's Gene Set Enricher web service (<http://ctdbase.org/tools/enricher.go>) was used to perform the enrichment analysis and a Bonferroni corrected p-value of 0.01 was chosen as a statistical significance cutoff. Lastly, when such enrichment was observed, we calculated the proportion of proteins involved in each enriched pathway as a way to assess whether any zones display functional specialization.

Cancer gene expression data sources
-----------------------------------

We consider gene expression absence/presence calls from the following cancers types: breast, lung, kidney, pancreas, liver, cervix, ovary, glioblastoma, pituitary, glioma, fallopian, endometrium and rectum, which was downloaded from Gene Expression Barcode database (<http://barcode.luhs.org/index.php?page=genesexp>). Genes expressed in at least 99% of samples of a cancer of interest based on the Human HGU133 platform were downloaded. Gene expression was used as a proxy for protein expression and was mapped onto the PINs of interest in order to identify the zones in which gene product is located in.

Testing the difference between proportions
------------------------------------------

We perform a z-test for the difference between two population proportions *p*~1~ and *p*~2~. We identify the null and alternative hypotheses and we specify the level of significance to be P \< 0.01. After that we determine the critical value(s) from the statistic table. Finally we find the standardized test statistic as showing below.

Statistical significance of the proportional analysis of pathway representation of zones
----------------------------------------------------------------------------------------

To test differences between proportions among zones, we need a statistical comparison of observed differences. A two-sample z-test for the difference between proportions for the top statistically enriched REACTOME pathways among zones was conducted. We defined the null hypothesis *H*~0~ to be: classification proportions of zones in the periphery in human PINs are as have high proportion significance as zones closest to the centre, i.e the accuracy of the sensing function are in zones closest to the centre and the accuracy of metabolic function are in zones in the periphery. If the *P*\<0.01, we rejected *H*~0~ and concluded that the proportions support our claim that zones closest to the centre have high proportion significance than the zones in the periphery. In the other words, we have enough evidence at the 1% level to conclude that zones closest to the centre have high proportion significance than the zones in the periphery.

Competing interests
===================

The authors declare that they have no competing interests.

Authors' contributions
======================

EF implemented the algorithms, performed the analyses and drafted the original manuscript. ECM proposed the concept of analyzing PINs as a metric spaces and oversaw the topological and statistical analyses. JG designed and oversaw and assisted in the functional evaluation tests and the biological interpretation of the results. ECM and JG supervised the study and edited the manuscript. All authors have read and approved the final manuscript.

Supplementary Material
======================

###### Additional file 1

**KEGG melanoma pathway.** Zone 1: red, zone 2: orange.
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###### Additional file 2

**KEGG measles pathway.** (Zone 1: red, zone 2: orange, zone 3: yellow), zone 4: green.
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###### Additional file 3

**KEGG inflammatory bowel disease pathway.** (Zone 1: red, zone 2: orange, zone 3: yellow, zone 4: green).
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###### Additional file 4

**disease pathway.** (Zone 1: red, zone 2: orange, zone 3: yellow, zone 4: green).
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